DANIEL ZHANG

Daniel Zhang serves as a Principal at Silversmith Capital Partners, a prominent growth equity firm based in Boston. In his role, Daniel is instrumental in sourcing, evaluating, and executing new investment opportunities, as well as providing ongoing strategic support to Silversmith's portfolio companies. His work is primarily concentrated on the firm's investments in healthcare IT and services, alongside software-as-a-service (SaaS) and information services sectors.

At Silversmith Capital Partners, Daniel Zhang leverages his deep industry knowledge to partner with exceptional management teams, helping them scale their businesses and achieve their full potential. He is particularly focused on companies that demonstrate strong market leadership, innovative technology, and significant growth prospects within their respective niches. His contributions are vital to Silversmith's mission of investing in profitable, growing technology and healthcare companies.

Prior to joining Silversmith in 2017, Daniel honed his investment acumen at TA Associates, another leading private equity firm. There, he gained valuable experience across a range of industries, further developing his analytical and deal execution skills. Before his tenure at TA Associates, Daniel began his career as an Analyst at Lazard, a global financial advisory and asset management firm, where he worked on various mergers and acquisitions and strategic advisory assignments. This foundational experience provided him with a comprehensive understanding of corporate finance and market dynamics.

Daniel is an alumnus of Harvard College, where he earned his Bachelor of Arts degree in Economics. His academic background, combined with his extensive professional experience, equips him with a robust framework for evaluating complex investment opportunities and navigating competitive markets. His notable involvement in Silversmith's portfolio companies includes contributions to firms such as ActiveCampaign, Centauri Health Solutions, HealthDrive, LifeStance Health, Net Health, Nordic Consulting, Panalgo, ProviderTrust, Upperline Health, and Validity. Through these engagements, Daniel Zhang continues to demonstrate his commitment to fostering innovation and driving significant value creation in the growth equity landscape.